GO:0006521 | regulation of cellular amino acid metabolic process | 5.52e-08 | 5.39e-04 | 6.574 | 4 | 16 | 41 |
GO:0000502 | proteasome complex | 9.69e-08 | 9.46e-04 | 6.377 | 4 | 17 | 47 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.47e-07 | 1.43e-03 | 6.231 | 4 | 17 | 52 |
GO:0005654 | nucleoplasm | 1.55e-07 | 1.52e-03 | 3.157 | 8 | 55 | 876 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 1.59e-07 | 1.55e-03 | 6.204 | 4 | 17 | 53 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.99e-07 | 1.94e-03 | 6.124 | 4 | 17 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.13e-07 | 2.08e-03 | 6.099 | 4 | 16 | 57 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.63e-07 | 2.57e-03 | 6.025 | 4 | 17 | 60 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.81e-07 | 2.75e-03 | 6.001 | 4 | 16 | 61 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.64e-07 | 3.56e-03 | 5.909 | 4 | 17 | 65 |
GO:0005839 | proteasome core complex | 4.30e-07 | 4.20e-03 | 7.516 | 3 | 9 | 16 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.92e-07 | 4.81e-03 | 5.802 | 4 | 16 | 70 |
GO:0004298 | threonine-type endopeptidase activity | 5.22e-07 | 5.10e-03 | 7.429 | 3 | 9 | 17 |
GO:0016032 | viral process | 1.24e-06 | 1.21e-02 | 3.775 | 6 | 32 | 428 |
GO:0000209 | protein polyubiquitination | 1.48e-06 | 1.45e-02 | 5.408 | 4 | 16 | 92 |
GO:0005829 | cytosol | 1.89e-06 | 1.85e-02 | 2.298 | 9 | 58 | 1787 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.52e-06 | 2.46e-02 | 5.217 | 4 | 18 | 105 |
GO:0042981 | regulation of apoptotic process | 3.27e-06 | 3.19e-02 | 5.124 | 4 | 18 | 112 |
GO:0010467 | gene expression | 4.57e-06 | 4.47e-02 | 3.453 | 6 | 31 | 535 |
GO:0000082 | G1/S transition of mitotic cell cycle | 5.06e-06 | 4.94e-02 | 4.966 | 4 | 24 | 125 |
GO:0016071 | mRNA metabolic process | 1.72e-05 | 1.68e-01 | 4.522 | 4 | 21 | 170 |
GO:0070062 | extracellular vesicular exosome | 2.05e-05 | 2.00e-01 | 2.251 | 8 | 43 | 1641 |
GO:0016070 | RNA metabolic process | 2.55e-05 | 2.49e-01 | 4.377 | 4 | 21 | 188 |
GO:0044281 | small molecule metabolic process | 6.35e-05 | 6.20e-01 | 2.795 | 6 | 32 | 844 |
GO:0006259 | DNA metabolic process | 8.53e-05 | 8.33e-01 | 7.124 | 2 | 3 | 14 |
GO:0000278 | mitotic cell cycle | 1.89e-04 | 1.00e+00 | 3.637 | 4 | 35 | 314 |
GO:0043066 | negative regulation of apoptotic process | 2.08e-04 | 1.00e+00 | 3.601 | 4 | 20 | 322 |
GO:0005634 | nucleus | 3.45e-04 | 1.00e+00 | 1.437 | 9 | 67 | 3246 |
GO:0016020 | membrane | 4.75e-04 | 1.00e+00 | 2.279 | 6 | 38 | 1207 |
GO:0006915 | apoptotic process | 5.31e-04 | 1.00e+00 | 3.248 | 4 | 21 | 411 |
GO:0006281 | DNA repair | 9.54e-04 | 1.00e+00 | 3.851 | 3 | 19 | 203 |
GO:0032558 | adenyl deoxyribonucleotide binding | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0004151 | dihydroorotase activity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.08e-03 | 1.00e+00 | 5.317 | 2 | 3 | 49 |
GO:0006310 | DNA recombination | 1.13e-03 | 1.00e+00 | 5.288 | 2 | 6 | 50 |
GO:0030891 | VCB complex | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 2 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 2 |
GO:0008296 | 3'-5'-exodeoxyribonuclease activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 2 |
GO:0032407 | MutSalpha complex binding | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 2 |
GO:0016363 | nuclear matrix | 2.39e-03 | 1.00e+00 | 4.742 | 2 | 7 | 73 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 3 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 3 |
GO:0000056 | ribosomal small subunit export from nucleus | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 3 |
GO:0051414 | response to cortisol | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 4 |
GO:0071169 | establishment of protein localization to chromatin | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0043248 | proteasome assembly | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0000055 | ribosomal large subunit export from nucleus | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0008853 | exodeoxyribonuclease III activity | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0032405 | MutLalpha complex binding | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0005730 | nucleolus | 4.37e-03 | 1.00e+00 | 2.004 | 5 | 41 | 1217 |
GO:0042802 | identical protein binding | 4.69e-03 | 1.00e+00 | 3.049 | 3 | 7 | 354 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 2 | 5 |
GO:0014075 | response to amine | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 6 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 6 |
GO:0075733 | intracellular transport of virus | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 7 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 2 | 7 |
GO:0000812 | Swr1 complex | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 2 | 7 |
GO:0045116 | protein neddylation | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 7 |
GO:0031011 | Ino80 complex | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 8 |
GO:0032479 | regulation of type I interferon production | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 9 |
GO:0008266 | poly(U) RNA binding | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 9 |
GO:0006541 | glutamine metabolic process | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 10 |
GO:0035458 | cellular response to interferon-beta | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 10 |
GO:0043968 | histone H2A acetylation | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 10 |
GO:0005838 | proteasome regulatory particle | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 4 | 10 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 2 | 11 |
GO:0008408 | 3'-5' exonuclease activity | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 1 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 3 | 12 |
GO:0048863 | stem cell differentiation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 12 |
GO:0071392 | cellular response to estradiol stimulus | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 13 |
GO:0035066 | positive regulation of histone acetylation | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 13 |
GO:0000738 | DNA catabolic process, exonucleolytic | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 13 |
GO:0010243 | response to organonitrogen compound | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 14 |
GO:0022624 | proteasome accessory complex | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 7 | 14 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 16 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 16 |
GO:0005719 | nuclear euchromatin | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 16 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 2 | 17 |
GO:0006513 | protein monoubiquitination | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 1 | 17 |
GO:0006298 | mismatch repair | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 4 | 17 |
GO:0007052 | mitotic spindle organization | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 2 | 17 |
GO:0005515 | protein binding | 1.78e-02 | 1.00e+00 | 0.922 | 8 | 76 | 4124 |
GO:0006611 | protein export from nucleus | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 18 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 18 |
GO:0003678 | DNA helicase activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 3 | 18 |
GO:0071339 | MLL1 complex | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 18 |
GO:0043234 | protein complex | 1.85e-02 | 1.00e+00 | 3.217 | 2 | 8 | 210 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 20 |
GO:0019005 | SCF ubiquitin ligase complex | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 20 |
GO:0017144 | drug metabolic process | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 21 |
GO:0043967 | histone H4 acetylation | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 2 | 22 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 22 |
GO:0007286 | spermatid development | 2.33e-02 | 1.00e+00 | 5.408 | 1 | 1 | 23 |
GO:0004003 | ATP-dependent DNA helicase activity | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 2 | 25 |
GO:0034644 | cellular response to UV | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 28 |
GO:0018107 | peptidyl-threonine phosphorylation | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 2 | 29 |
GO:0050681 | androgen receptor binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 30 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 3.13e-02 | 1.00e+00 | 4.977 | 1 | 2 | 31 |
GO:0043195 | terminal bouton | 3.13e-02 | 1.00e+00 | 4.977 | 1 | 1 | 31 |
GO:0031490 | chromatin DNA binding | 3.13e-02 | 1.00e+00 | 4.977 | 1 | 1 | 31 |
GO:0007595 | lactation | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 2 | 32 |
GO:0019003 | GDP binding | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 1 | 34 |
GO:0014070 | response to organic cyclic compound | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 1 | 34 |
GO:0032092 | positive regulation of protein binding | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 1 | 34 |
GO:0030521 | androgen receptor signaling pathway | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 35 |
GO:0040008 | regulation of growth | 3.73e-02 | 1.00e+00 | 4.722 | 1 | 2 | 37 |
GO:0035690 | cellular response to drug | 3.83e-02 | 1.00e+00 | 4.684 | 1 | 2 | 38 |
GO:0032508 | DNA duplex unwinding | 3.83e-02 | 1.00e+00 | 4.684 | 1 | 5 | 38 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 2 | 40 |
GO:0042995 | cell projection | 4.12e-02 | 1.00e+00 | 4.574 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 4.12e-02 | 1.00e+00 | 4.574 | 1 | 9 | 41 |
GO:0031100 | organ regeneration | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 2 | 44 |
GO:0032481 | positive regulation of type I interferon production | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 5 | 48 |
GO:0005643 | nuclear pore | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 2 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 5 | 51 |
GO:0006338 | chromatin remodeling | 5.49e-02 | 1.00e+00 | 4.150 | 1 | 2 | 55 |
GO:0005681 | spliceosomal complex | 5.49e-02 | 1.00e+00 | 4.150 | 1 | 2 | 55 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 3 | 56 |
GO:0003697 | single-stranded DNA binding | 5.69e-02 | 1.00e+00 | 4.099 | 1 | 6 | 57 |
GO:0000785 | chromatin | 5.88e-02 | 1.00e+00 | 4.049 | 1 | 5 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 6.08e-02 | 1.00e+00 | 4.001 | 1 | 5 | 61 |
GO:0007565 | female pregnancy | 6.37e-02 | 1.00e+00 | 3.931 | 1 | 2 | 64 |
GO:0042470 | melanosome | 6.37e-02 | 1.00e+00 | 3.931 | 1 | 2 | 64 |
GO:0006325 | chromatin organization | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 4 | 70 |
GO:0001889 | liver development | 7.04e-02 | 1.00e+00 | 3.782 | 1 | 1 | 71 |
GO:0001649 | osteoblast differentiation | 7.33e-02 | 1.00e+00 | 3.722 | 1 | 2 | 74 |
GO:0015630 | microtubule cytoskeleton | 7.42e-02 | 1.00e+00 | 3.703 | 1 | 2 | 75 |
GO:0071456 | cellular response to hypoxia | 7.52e-02 | 1.00e+00 | 3.684 | 1 | 2 | 76 |
GO:0019058 | viral life cycle | 7.71e-02 | 1.00e+00 | 3.646 | 1 | 3 | 78 |
GO:0030529 | ribonucleoprotein complex | 8.09e-02 | 1.00e+00 | 3.574 | 1 | 4 | 82 |
GO:0003690 | double-stranded DNA binding | 8.19e-02 | 1.00e+00 | 3.556 | 1 | 3 | 83 |
GO:0005635 | nuclear envelope | 8.19e-02 | 1.00e+00 | 3.556 | 1 | 4 | 83 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 9.04e-02 | 1.00e+00 | 3.408 | 1 | 2 | 92 |
GO:0006260 | DNA replication | 9.22e-02 | 1.00e+00 | 3.377 | 1 | 11 | 94 |
GO:0007219 | Notch signaling pathway | 9.32e-02 | 1.00e+00 | 3.362 | 1 | 4 | 95 |
GO:0006457 | protein folding | 9.51e-02 | 1.00e+00 | 3.332 | 1 | 4 | 97 |
GO:0016887 | ATPase activity | 9.79e-02 | 1.00e+00 | 3.288 | 1 | 6 | 100 |
GO:0007507 | heart development | 1.03e-01 | 1.00e+00 | 3.204 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 1.03e-01 | 1.00e+00 | 3.204 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 1.06e-01 | 1.00e+00 | 3.163 | 1 | 3 | 109 |
GO:0003924 | GTPase activity | 1.15e-01 | 1.00e+00 | 3.037 | 1 | 3 | 119 |
GO:0004672 | protein kinase activity | 1.21e-01 | 1.00e+00 | 2.966 | 1 | 2 | 125 |
GO:0000398 | mRNA splicing, via spliceosome | 1.24e-01 | 1.00e+00 | 2.931 | 1 | 8 | 128 |
GO:0006184 | GTP catabolic process | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 3 | 130 |
GO:0032403 | protein complex binding | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 2 | 130 |
GO:0019904 | protein domain specific binding | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 2 | 130 |
GO:0031625 | ubiquitin protein ligase binding | 1.33e-01 | 1.00e+00 | 2.823 | 1 | 5 | 138 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.36e-01 | 1.00e+00 | 2.782 | 1 | 2 | 142 |
GO:0005622 | intracellular | 1.39e-01 | 1.00e+00 | 2.752 | 1 | 1 | 145 |
GO:0008380 | RNA splicing | 1.57e-01 | 1.00e+00 | 2.565 | 1 | 7 | 165 |
GO:0007067 | mitotic nuclear division | 1.57e-01 | 1.00e+00 | 2.565 | 1 | 8 | 165 |
GO:0043025 | neuronal cell body | 1.62e-01 | 1.00e+00 | 2.514 | 1 | 3 | 171 |
GO:0007264 | small GTPase mediated signal transduction | 1.65e-01 | 1.00e+00 | 2.489 | 1 | 1 | 174 |
GO:0000166 | nucleotide binding | 1.66e-01 | 1.00e+00 | 2.472 | 1 | 6 | 176 |
GO:0008270 | zinc ion binding | 1.68e-01 | 1.00e+00 | 1.426 | 2 | 7 | 727 |
GO:0004842 | ubiquitin-protein transferase activity | 1.69e-01 | 1.00e+00 | 2.448 | 1 | 2 | 179 |
GO:0003713 | transcription coactivator activity | 1.73e-01 | 1.00e+00 | 2.408 | 1 | 5 | 184 |
GO:0016567 | protein ubiquitination | 1.77e-01 | 1.00e+00 | 2.377 | 1 | 3 | 188 |
GO:0005525 | GTP binding | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 5 | 197 |
GO:0044822 | poly(A) RNA binding | 1.95e-01 | 1.00e+00 | 1.289 | 2 | 25 | 799 |
GO:0019899 | enzyme binding | 1.95e-01 | 1.00e+00 | 2.217 | 1 | 4 | 210 |
GO:0006200 | ATP catabolic process | 2.03e-01 | 1.00e+00 | 2.157 | 1 | 8 | 219 |
GO:0003723 | RNA binding | 2.26e-01 | 1.00e+00 | 1.983 | 1 | 11 | 247 |
GO:0003682 | chromatin binding | 2.30e-01 | 1.00e+00 | 1.954 | 1 | 6 | 252 |
GO:0005524 | ATP binding | 2.31e-01 | 1.00e+00 | 1.131 | 2 | 23 | 892 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.26e-01 | 1.00e+00 | 1.373 | 1 | 10 | 377 |
GO:0005789 | endoplasmic reticulum membrane | 3.33e-01 | 1.00e+00 | 1.335 | 1 | 1 | 387 |
GO:0042803 | protein homodimerization activity | 3.61e-01 | 1.00e+00 | 1.190 | 1 | 5 | 428 |
GO:0045087 | innate immune response | 3.78e-01 | 1.00e+00 | 1.111 | 1 | 7 | 452 |
GO:0007165 | signal transduction | 4.80e-01 | 1.00e+00 | 0.660 | 1 | 5 | 618 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.95e-01 | 1.00e+00 | 0.601 | 1 | 8 | 644 |
GO:0046872 | metal ion binding | 6.34e-01 | 1.00e+00 | 0.064 | 1 | 10 | 934 |
GO:0006351 | transcription, DNA-templated | 6.89e-01 | 1.00e+00 | -0.140 | 1 | 9 | 1076 |
GO:0005737 | cytoplasm | 7.98e-01 | 1.00e+00 | -0.431 | 2 | 50 | 2633 |